HFA Premium Access

Panel discussion and summary - Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death.

Congress Presentation

About the speaker

Professor Christophe Leclercq

Hospital Pontchaillou of Rennes, Rennes (France)
59 presentations
9 followers

4 more presentations in this session

Introduction - Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death

Speaker: Professor L. Kober (Copenhagen, DK)

Thumbnail

Distilling the clinical evidence behind the WCD - What have clinical trials and registries told us?

Speaker: Professor C. Veltmann (Bremen, DE)

Thumbnail

Taking your time in the treatment of newly diagnosed heart failure patients.

Speaker: Doctor J. Erath (Frankfurt, DE)

Thumbnail

The impact of the WCD for patients who choose to wear it.

Speaker: Professor A. Flammer (Zurich, CH)

Thumbnail

Access the full session

Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death

Speakers: Professor C. Leclercq, Professor L. Kober, Professor C. Veltmann, Doctor J. Erath, Professor A. Flammer
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb